Urokinase
اوروکیناز
🩸 Blood And Blood Forming OrgansThrombolytic
Market / country: 🇺🇸 USA
Kinlytic (US)
🧮 Dose calculator
Pulmonary embolism · Regimen source: FDA Kinlytic · Dosage and Administration
- • The calculator gives the loading dose; the maintenance infusion is the same amount per hour for 12 h. Start as soon as possible after PE onset. Afterwards, heparin without a bolus. FDA Kinlytic · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Active internal bleeding; stroke, intracranial or intraspinal surgery within 2 months; recent trauma including CPR; intracranial neoplasm, AVM or aneurysm; bleeding diathesis; severe uncontrolled hypertension; hypersensitivity. FDA Kinlytic · Contraindications
Warnings
- • Serious and fatal bleeding (intracranial, retroperitoneal); higher with other anticoagulants. FDA Kinlytic · Warnings
Formulations
- 250,000 IU vial — powder for injection 🇺🇸 USA FDA Kinlytic · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Kinlytic · Pregnancy
“Pregnancy Category B: Reproduction studies have been performed in mice and rats at doses up to 1,000 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to Kinlytic™.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Kinlytic · Nursing Mothers
“Because many drugs are excreted in human milk, caution should be exercised when Kinlytic™ is administered to a nursing woman.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Kinlytic · Pediatric Use
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Kinlytic · Geriatric Use
“Kinlytic™ should be used with caution in elderly patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)❌ None
- DailyMed (FDA label)FDA Kinlytic
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDB01AD04
- Darooyab (Iran)Urokinase
🇮🇷 Registered in Iran Darooyab · G-1928/Urokinase
Dosage forms with Iranian generic codes, per Darooyab.
- 01271 · UROKINASE 250,000U VIAL · ویال اوروکیناس ۲۵۰ ۰۰۰ واحد
- 01272 · UROKINASE 75,000U VIAL · ویال اوروکیناس ۷۵ ۰۰۰ واحد
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Kinlytic · How SuppliedFDA Kinlytic · Dosage and AdministrationFDA Kinlytic · ContraindicationsFDA Kinlytic · WarningsFDA Kinlytic · PregnancyFDA Kinlytic · Nursing MothersFDA Kinlytic · Pediatric UseFDA Kinlytic · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1928/Urokinase
- Clinical review⚠ Unverified